Medicine to reverse stomach precancerous changes
Part of Cancer, Digestive system clinical trials.
This study tests a medicine called pyrvinium to see if it can reverse early changes in the stomach lining that may lead to stomach cancer. It may help prevent stomach cancer from developing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 21 years old.
- You have certain precancerous changes in your stomach lining, confirmed by a biopsy, that are widespread or advanced.
- You are willing to give written informed consent to participate.
- You must not have had stomach cancer before or have it now.
- You must not have had surgery to remove part or all of your stomach.
- You must be willing to pause certain blood-thinning medicines before procedures, if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
This study tests whether berberine, a natural compound, can help reverse or slow the progression of gastric intestinal metaplasia, a precancerous condition in the stomach lining. Participation involves taking the medication and monitoring your stomach health over time.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
Hear when a new STOMACH NEOPLASM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.